Blue Crest Capital Management LTD Halozyme Therapeutics, Inc. Transaction History

Blue Crest Capital Management LTD

  • $1.62 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$13.33 - $18.66 $145,750 - $204,028
-10,934 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$16.68 - $18.41 $182,379 - $201,294
10,934 New
10,934 $199,000
Q2 2018

Aug 14, 2018
SELL
$16.87 - $20.3 $175,346 - $210,998
-10,394 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$17.06 - $21.2 $177,321 - $220,352
10,394 New
10,394 $204,000

Others Institutions Holding HALO

# of Institutions
542
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $7.35B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email